NCT04906655View on ClinicalTrials.gov

An Open Label Study for Palmar Hyperhydrosis

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

May 20, 2021

Study Completion Date

May 20, 2021

Conditions

Palmar HyperhidrosisHyperhidrosisSweat Gland DiseasesSkin Diseases

Interventions

DRUG

Glycopyrronium 2.4 % Medicated Cloth

The investigational product (glycopyrronium cloth, 2.4%) is a pre-moistened, medicated cloth towelette that comes in individually wrapped packets. Subjects will receive marketed Qbrexza, one box, containing 30 pouches.

Trial Locations (1)

23502

Virginia Clinical Research, Inc., Norfolk

All Listed Sponsors

lead

Pariser, Robert J., M.D.

OTHER

collaborator

Virginia Clinical Research, Inc.

OTHER

NCT04906655 - An Open Label Study for Palmar Hyperhydrosis | Biotech Hunter | Biotech Hunter